Certara, Inc. (NASDAQ:CERT) Receives Consensus Rating of “Moderate Buy” from Brokerages

Certara, Inc. (NASDAQ:CERT) has been assigned a consensus rating of “Moderate Buy” from the eight research firms that are presently covering the firm, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $15.83.

Several analysts have issued reports on the stock. Stephens restated an “overweight” rating and set a $17.00 price target on shares of Certara in a research report on Thursday, February 27th. Barclays upped their price target on shares of Certara from $12.00 to $13.00 and gave the company an “equal weight” rating in a research report on Friday, February 28th. William Blair restated a “market perform” rating on shares of Certara in a research report on Thursday, February 27th. Finally, TD Cowen assumed coverage on shares of Certara in a research report on Thursday, February 27th. They set a “buy” rating and a $16.00 price target for the company.

Institutional Trading of Certara

Institutional investors have recently modified their holdings of the company. Venturi Wealth Management LLC boosted its holdings in shares of Certara by 839.1% during the fourth quarter. Venturi Wealth Management LLC now owns 2,808 shares of the company’s stock worth $30,000 after purchasing an additional 2,509 shares during the period. Wells Fargo & Company MN boosted its holdings in shares of Certara by 48.4% during the fourth quarter. Wells Fargo & Company MN now owns 3,208 shares of the company’s stock worth $34,000 after purchasing an additional 1,047 shares during the period. Blue Trust Inc. boosted its holdings in shares of Certara by 112.3% during the third quarter. Blue Trust Inc. now owns 3,925 shares of the company’s stock worth $46,000 after purchasing an additional 2,076 shares during the period. Johnson Financial Group Inc. purchased a new stake in shares of Certara during the fourth quarter worth about $47,000. Finally, KBC Group NV boosted its holdings in shares of Certara by 48.2% during the third quarter. KBC Group NV now owns 4,873 shares of the company’s stock worth $57,000 after purchasing an additional 1,584 shares during the period. 73.96% of the stock is currently owned by hedge funds and other institutional investors.

Certara Stock Up 0.5 %

Shares of NASDAQ:CERT opened at $11.91 on Thursday. Certara has a 52-week low of $9.41 and a 52-week high of $19.87. The firm has a fifty day moving average of $12.52 and a 200 day moving average of $11.63. The firm has a market capitalization of $1.92 billion, a PE ratio of -59.55, a price-to-earnings-growth ratio of 9.29 and a beta of 1.60. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.86 and a current ratio of 2.86.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.